Cargando…

In‐depth molecular analysis of combined and co‐primary pulmonary large cell neuroendocrine carcinoma and adenocarcinoma

Up to 14% of large cell neuroendocrine carcinomas (LCNECs) are diagnosed in continuity with nonsmall cell lung carcinoma. In addition to these combined lesions, 1% to 7% of lung tumors present as co‐primary tumors with multiple synchronous lesions. We evaluated molecular and clinicopathological char...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hermans, Bregtje C. M., Derks, Jules L., Hillen, Lisa M., van der Baan, Irene, van den Broek, Esther C., von der Thüsen, Jan H., van Suylen, Robert‐Jan, Atmodimedjo, Peggy N., den Toom, T. Dorine, Coumans‐Stallinga, Cecile, Timens, Wim, Dinjens, Winand N. M., Dubbink, Hendrikus J., Speel, Ernst‐Jan M., Dingemans, Anne‐Marie C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Cancer Genetics and Epigenetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298697/ https://www.ncbi.nlm.nih.gov/pubmed/34674268 http://dx.doi.org/10.1002/ijc.33853

Ejemplares similares

Development and verification of new monoclonal orthopedia homeobox (OTP) specific antibodies for pulmonary carcinoid diagnostics
por: Moonen, Laura, et al.
Publicado: (2022)

Is the sum of positive neuroendocrine immunohistochemical stains useful for diagnosis of large cell neuroendocrine carcinoma (LCNEC) on biopsy specimens?
por: Derks, Jules L, et al.
Publicado: (2019)

Large cell neuroendocrine carcinoma with a solitary brain metastasis and low Ki-67: a unique subtype
por: Hermans, B C M, et al.
Publicado: (2019)

“The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology”: letter to the Editor
por: Dinjens, Winand N. M., et al.
Publicado: (2020)

Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?
por: Derks, Jules L., et al.
Publicado: (2017)

Mitochondrial D310 mutation as clonal marker for solid tumors
por: Geurts-Giele, Willemina R. R., et al.
Publicado: (2015)

Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics
por: Synhaeve, Nathalie E., et al.
Publicado: (2018)

Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer
por: Steendam, Christi M. J., et al.
Publicado: (2020)

Novel EGFR V834L Germline Mutation Associated With Familial Lung Adenocarcinoma
por: van der Leest, Cor, et al.
Publicado: (2018)

MET immunochemistry: a reliable screening tool for MET exon 14 skipping mutations in non-small cell lung cancer?
por: Pruis, Melinda A., et al.
Publicado: (2020)

Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma
por: Wijnenga, Maarten M. J., et al.
Publicado: (2018)

MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation
por: Groenendijk, Floris H., et al.
Publicado: (2010)

A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory
por: Van Lier, Margot GF, et al.
Publicado: (2010)

Differences in spatial distribution between WHO 2016 low-grade glioma molecular subgroups
por: Wijnenga, Maarten M J, et al.
Publicado: (2019)

Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity
por: van den Broek, Daan, et al.
Publicado: (2020)

Personalised selection of experimental treatment in patients with advanced solid cancer is feasible using whole-genome sequencing
por: Pruis, Melinda A., et al.
Publicado: (2022)

Comparison of variant allele frequency and number of mutant molecules as units of measurement for circulating tumor DNA
por: Bos, Manouk K., et al.
Publicado: (2020)

Orthopedia Homeobox (OTP) in Pulmonary Neuroendocrine Tumors: The Diagnostic Value and Possible Molecular Interactions
por: Moonen, Laura, et al.
Publicado: (2019)

Liquid biopsy in esophageal cancer: a case report of false-positive circulating tumor DNA detection due to clonal hematopoiesis
por: Spoor, Jonathan, et al.
Publicado: (2021)

Algorithm for Bosniak 2F Cyst in Kidney Donation
por: Minnee, Robert C., et al.
Publicado: (2017)

The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype Glioblastoma
por: Incekara, Fatih, et al.
Publicado: (2020)

Prevalence of c-KIT Mutations in Gonadoblastoma and Dysgerminomas of Patients with Disorders of Sex Development (DSD) and Ovarian Dysgerminomas
por: Hersmus, Remko, et al.
Publicado: (2012)

Real-World Approach for Molecular Analysis of Acquired EGFR Tyrosine Kinase Inhibitor Resistance Mechanisms in NSCLC
por: Hondelink, Liesbeth M., et al.
Publicado: (2021)

Gynecological Surveillance and Surgery Outcomes in Dutch Lynch Syndrome Carriers
por: Eikenboom, Ellis L., et al.
Publicado: (2021)

Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer
por: Dingemans, Anne-Marie C, et al.
Publicado: (2010)

Topographical Mapping of 436 Newly Diagnosed IDH Wildtype Glioblastoma With vs. Without MGMT Promoter Methylation
por: Incekara, Fatih, et al.
Publicado: (2020)

Unexplained mismatch repair deficiency: Case closed
por: Eikenboom, Ellis L., et al.
Publicado: (2022)

Galectin Expression Profiling Identifies Galectin-1 and Galectin-9Δ5 as Prognostic Factors in Stage I/II Non-Small Cell Lung Cancer
por: Schulkens, Iris A., et al.
Publicado: (2014)

TP53 Mutations in Serum Circulating Cell-Free Tumor DNA As Longitudinal Biomarker for High-Grade Serous Ovarian Cancer
por: Vitale, Silvia R., et al.
Publicado: (2020)

Pulmonary veno-occlusive disease as a cause of severe pulmonary hypertension in a dog
por: den Toom, Marjolein Lisette, et al.
Publicado: (2018)

Impact of panel design and cut-off on tumour mutational burden assessment in metastatic solid tumour samples
por: Mankor, Joanne M., et al.
Publicado: (2020)

Detection of circulating tumour DNA after neoadjuvant chemoradiotherapy in patients with locally advanced oesophageal cancer
por: Eyck, Ben M, et al.
Publicado: (2022)

A mononucleotide repeat in PRRT2 is an important, frequent target of mismatch repair deficiency in cancer
por: Alves, Inês Teles, et al.
Publicado: (2016)

Combined germline pathogenic variants in FLCN and TP53 are associated with early onset renal cell carcinoma and brain tumors
por: van de Beek, Irma, et al.
Publicado: (2022)

The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder
por: van Doeveren, Thomas, et al.
Publicado: (2020)

Formalin fixation for optimal concordance of programmed death‐ligand 1 immunostaining between cytologic and histologic specimens from patients with non–small cell lung cancer
por: Koomen, Bregje M., et al.
Publicado: (2020)

Recommendations for the clinical interpretation and reporting of copy number gains using gene panel NGS analysis in routine diagnostics
por: Eijkelenboom, Astrid, et al.
Publicado: (2019)

Differential Orthopedia Homeobox expression in pulmonary carcinoids is associated with changes in DNA methylation
por: Moonen, Laura, et al.
Publicado: (2022)

Histopathology and genetic susceptibility in COVID‐19 pneumonia
por: von der Thüsen, Jan, et al.
Publicado: (2020)

BRAF(V600E) immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells: A STROBE-Compliant article
por: Verlinden, Ivana, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_r0adh60ct8qae2v3imdgont24e